Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.39−0.03 (-0.39%)
Close on Nov 17, 2026Market cap $241.88MP/E –Yield –
Lifecore Biomedical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Lifecore Biomedical's pe ratio was 82.6× on Dec 31, 2024, against 14.4× a year earlier. Over the last 5 years it ranged from 13.3× to 82.6×, with a median of 22.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Dec 31, 2024 | 82.6× | +45.1 |
| 2019 | Jun 28, 2019 | 37.5× | +23.0 |
| 2018 | Dec 31, 2018 | 14.4× | −21.6 |
| 2017 | Dec 29, 2017 | 36.0× | +13.7 |
| 2016 | Mar 31, 2016 | 22.3× | −0.4 |
| 2015 | Dec 31, 2015 | 22.8× | +0.8 |
| 2014 | Dec 31, 2014 | 21.9× | +8.0 |
| 2013 | Dec 31, 2013 | 13.9× | −2.2 |
| 2012 | Dec 31, 2012 | 16.1× | −23.3 |
| 2011 | Dec 30, 2011 | 39.4× | −0.4 |
| 2010 | Dec 31, 2010 | 39.9× | – |
See a number that looks wrong?